GE HealthCare Technologies (GEHC) return on equity (ROE)

Return on equity · fiscal 2025
20.1%

GE HealthCare Technologies (GEHC) earned a return on equity of 20.1% in fiscal 2025 (the year ended December 31, 2025). That is 3.5 percentage points lower than the 23.6% of fiscal 2024. Figures as of 17 Nov 2026, 21:30 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
20.1%
Change on fiscal 2024
−3.5 pts
Highest on record
23.6%fiscal 2024
Lowest on record
13.5%fiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

GE HealthCare Technologies return on equity (ROE), in more detail

Across the 5 fiscal years on record (2021–2025), the highest was 23.6% in fiscal 2024 and the lowest 13.5% in fiscal 2021. The fiscal 2025 figure is higher than in 25% of the 4 earlier fiscal years on record, whose median is 21.2%.

History · 5 fiscal years

Return on equity by fiscal year

GE HealthCare Technologies return on equity (ROE), year by year

GE HealthCare Technologies (GEHC) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202520.1% 3.5 pts down
202423.6% 1.6 pts up
202322.0% 1.5 pts up
202220.5% 7.0 pts up
202113.5%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of GE HealthCare Technologies and comparable companies
CompanyReturn on equityFiscal year
Royalty Pharma RPRX11.9%2025
Biogen BIIB7.1%2025
GE HealthCare Technologies GEHC20.1%2025
Alcon ALC4.4%2025
Mettler-Toledo International MTD3519.1%2022
Centene CNC-33.4%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GEHC

GE HealthCare Technologies, figure by figure

GE HealthCare Technologies (GEHC) overview: price, valuation and scorecardAll health care companies by market value

GE HealthCare Technologies return on equity (ROE): questions and answers

What is GE HealthCare Technologies's return on equity?

GE HealthCare Technologies (GEHC) earned a return on equity of 20.1% in fiscal 2025 (the year ended December 31, 2025). That is 3.5 percentage points lower than the 23.6% of fiscal 2024.

Is GE HealthCare Technologies's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 25% of the 4 earlier fiscal years on record, whose median is 21.2%.

What are the highest and lowest return on equity figures on record for GE HealthCare Technologies?

Across the 5 fiscal years on record (2021–2025), the highest was 23.6% in fiscal 2024 and the lowest 13.5% in fiscal 2021.

How is GE HealthCare Technologies's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “GE HealthCare Technologies (GEHC) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/GEHC/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.